Guidelines for the management of bullous pemphigoid

• DOI: 10.1046/j.1365-2133.2002.04835.x
• Publication Date: 2003-03-11T05:48:46Z
• Authors: F. Wojnarowska; G. Kirtschig; A.S. Highet; V.A. Venning; N.P. Khumalo
• Keywords: Adult; Male; Administration, Topical; Anti-Inflammatory Agents; Anti-Bacterial Agents; 3. Good health; Diagnosis, Differential; 03 medical and health sciences; 0302 clinical medicine; Pemphigoid, Bullous; Humans; Female; Child; Glucocorticoids; Immunosuppressive Agents; Aged; Randomized Controlled Trials as Topic; Retrospective Studies

Summary These guidelines have been prepared for dermatologists on behalf of the British Association Dermatologists. They present evidence‐based guidance treatment, with identification strength evidence available at time preparation and a brief overview epidemiological aspects, diagnosis investigation. The reflect data from Medline, Embase, Cochrane library, literature searches experience authors managing patients bullous pemphigoid in special general clinics over 10 years. However, caution should be exercised interpreting obtained because only six randomized controlled trials are involving small groups patients.